Merck: Number of Employees 2006-2020 | MRK

Interactive chart of Merck (MRK) annual worldwide employee count from 2006 to 2020.
  • Merck total number of employees in 2019 was 71,000, a 2.9% increase from 2018.
  • Merck total number of employees in 2018 was 69,000, a 0% decline from 2017.
  • Merck total number of employees in 2017 was 69,000, a 1.47% increase from 2016.
  • Merck total number of employees in 2016 was 68,000, a 0% decline from 2015.
Merck Annual Number of Employees
2019 71,000
2018 69,000
2017 69,000
2016 68,000
2015 68,000
2014 70,000
2013 76,000
2012 83,000
2011 86,000
2010 94,000
2009 100,000
2008 55,200
2007 59,800
2006 60,000
2005 61,500
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $210.306B $46.840B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $380.891B 18.15
Roche Holding AG (RHHBY) Switzerland $306.127B 0.00
Pfizer (PFE) United States $198.714B 12.42
Novartis AG (NVS) Switzerland $197.515B 15.36
Novo Nordisk (NVO) Denmark $160.762B 26.16
AbbVie (ABBV) United States $151.617B 9.24
Eli Lilly (LLY) United States $142.332B 21.72
AstraZeneca (AZN) United Kingdom $142.162B 27.64
Sanofi (SNY) $127.185B 15.12
GlaxoSmithKline (GSK) United Kingdom $93.769B 12.30
Bayer (BAYRY) Germany $59.273B 8.54
H Lundbeck (HLUYY) Denmark $6.418B 11.15
Innoviva (INVA) United States $1.091B 5.22